Obesity has increased dramatically over the past 30 years in the US and is associated with increased mortality rates of various cancers, including prostate cancer (PCa). Insights into the mechanism(s) underiying the enhanced progression of PCa associated with obesity are urgently needed to develop new strategies for preventing and treating obesity related PCa. Recently, we have reported that obesity has a significant role in PCa progression for patients with localized disease independent of treatment (prostatectomy or radiation. Body mass index (BMI) appears to be an independent risk factor for either biochemical failure (BF) or clinical failure (CF) and our new data suggest that fat intake modulates tumor progression. In animal studies, we have recently found that positive (obese diet) and negative (calorie- restricted diet) energy balance modulate activity of the Akt/mTOR signaling pathway in several mouse tissues including the prostate. Finally, preliminary studies have shown enhanced progression of PCa in HiMyc transgenic mice maintained on an obesity-inducing high fat diet. Our data also suggest that enhanced signaling through Akt and mTOR may play a role in this enhanced progression associated with maintenance on an obesity-inducing diet. Taken together, these findings suggest that pathways activated by obesity, such as the Akt/mTOR pathways, may be key targets for preventing and controlling obesity-related PCa progression. In this project, we propose to use the well-characterized HiMyc mouse prostate tumor model, in combination with dietary and pharmacologic approaches, to test this hypothesis. Additionally, we will evaluate the relevance of changes in these signaling pathways (including both upstream and downstream components) using serum, germline DNA and tumor tissue from PCa patients who are part of ongoing studies at the UT MD Anderson Cancer Center. Findings from these proposed studies will provide the basis for future translational studies targeting specific pathways via lifestyle and pharmacologic approaches to reduce PCa specific mortality. The hypothesis to be tested in this proposal is that diet-induced obesity and/or high fat diet impacts PCa progression through modulation of Akt, mTOR and their downstream signaling pathways.
The specific aims are 1) To establish the impact and underiying mechanisms of enhanced PCa progression in HiMyc mice due to diet-induced obesity, 2) To characterize pharmacologic interventions that offset the increased risk of PCa progression associated with diet-induced obesity (DIO)/ high fat (HF) diet in HiMyc mice, and 3) To extend the dietary and intervention associations with PCa progression identified in Specific Aims 1 and 2 to two well-characterized populations of PCa patients.

Public Health Relevance

(See Instructions): In this project, we propose to use the well-characterized HiMyc mouse prostate tumor model, in combination with dietary and pharmacologic approaches, to test the hypothesis that diet-induced obesity and/or high fat diet impacts PCa progression through modulation of Akt, mTOR and their downstream signaling pathways. Additionally, we will evaluate the relevance of changes in these signaling pathways (including both upstream and downstream components) using serum, germline DNA and tumor tissue from PCa patients who are part of ongoing studies at the UT MD Anderson Cancer Center. Findings from these proposed studies will provide the basis for future translational studies targeting specific pathways via lifestyle and pharmacologic approaches to reduce PCa specific mortality.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
5P50CA140388-04
Application #
8380583
Study Section
Special Emphasis Panel (ZCA1-RPRB-7)
Project Start
Project End
Budget Start
2012-09-01
Budget End
2013-08-31
Support Year
4
Fiscal Year
2012
Total Cost
$234,485
Indirect Cost
$81,251
Name
University of Texas MD Anderson Cancer Center
Department
Type
DUNS #
800772139
City
Houston
State
TX
Country
United States
Zip Code
77030
Zhang, Tao; Tseng, Chieh; Zhang, Yan et al. (2016) CXCL1 mediates obesity-associated adipose stromal cell trafficking and function in the tumour microenvironment. Nat Commun 7:11674
Sun, Sheng; Sun, Le; Zhou, Xi et al. (2016) Phosphorylation-Dependent Activation of the ESCRT Function of ALIX in Cytokinetic Abscission and Retroviral Budding. Dev Cell 36:331-43
Hosoya, Hitomi; Dobroff, Andrey S; Driessen, Wouter H P et al. (2016) Integrated nanotechnology platform for tumor-targeted multimodal imaging and therapeutic cargo release. Proc Natl Acad Sci U S A 113:1877-82
Maity, Sankar N; Titus, Mark A; Gyftaki, Revekka et al. (2016) Targeting of CYP17A1 Lyase by VT-464 Inhibits Adrenal and Intratumoral Androgen Biosynthesis and Tumor Growth of Castration Resistant Prostate Cancer. Sci Rep 6:35354
Saha, Achinto; Blando, Jorge; Fernandez, Irina et al. (2016) Linneg Sca-1high CD49fhigh prostate cancer cells derived from the Hi-Myc mouse model are tumor-initiating cells with basal-epithelial characteristics and differentiation potential in vitro and in vivo. Oncotarget 7:25194-207
Han, Ying; Rand, Kristin A; Hazelett, Dennis J et al. (2016) Prostate Cancer Susceptibility in Men of African Ancestry at 8q24. J Natl Cancer Inst 108:
Varkaris, Andreas; Corn, Paul G; Parikh, Nila U et al. (2016) Integrating Murine and Clinical Trials with Cabozantinib to Understand Roles of MET and VEGFR2 as Targets for Growth Inhibition of Prostate Cancer. Clin Cancer Res 22:107-21
Fong, Eliza L S; Wan, Xinhai; Yang, Jun et al. (2016) A 3D in vitro model of patient-derived prostate cancer xenograft for controlled interrogation of in vivo tumor-stromal interactions. Biomaterials 77:164-72
Weiderhold, Kimberly N; Fadri-Moskwik, Maria; Pan, Jing et al. (2016) Dynamic Phosphorylation of NudC by Aurora B in Cytokinesis. PLoS One 11:e0153455
Qiao, Yuanyuan; Feng, Felix Y; Wang, Yugang et al. (2016) Mechanistic Support for Combined MET and AR Blockade in Castration-Resistant Prostate Cancer. Neoplasia 18:1-9

Showing the most recent 10 out of 167 publications